TY - CHAP M1 - Book, Section TI - Combination avelumab and axitinib treatment of advanced type B3 thymoma and thymic carcinoma is promising as second-line treatment after standard therapy. A1 - McFarlane, Kassandra A1 - Chan, Sze Wah Samuel Y1 - 2015 N1 - T2 - 2 Minute Medicine AB - SN - PB - McGraw Hill CY - New York, NY Y2 - 2024/03/28 UR - accessmedicine.mhmedical.com/updatesContent.aspx?gbosid=597624 ER -